VRK1 anticorps (N-Term)

N° du produit ABIN2452161

Détail du produit anti-VRK1 anticorps

Antigène: VRK1 (Vaccinia Related Kinase 1 (VRK1))

Épitope: N-Term

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp VRK1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (IF)

Specificité: Reacts with human VRK1 protein.

Réactivité croisée (Details): Not tested with other species.

Attributs du produit: Mouse monoclonal antibody (5D1) produced in serum-free medium and purified by propriety chromatography under mild conditions (90~98 % pure). Isotype,IgG1 kappa

Stérilité: Sterile filtered

Immunogène: Synthetic peptide corresponding to N-terminus of human VRK1,MPRVKAAQAGRQSSAKRHL-C

Clone: 5D1

Isotype: IgG2 kappa

Information d'application

Indications d'application: 1. Western blotting: 1/200~1/1,000 dilution. Use of highly sensitive chemiluminescence reagents such as Lumi-Light Plus (Roche) or ImmunoStaroR LD (Wako,Tokyo) are recommended.
2. Immunoprecipitation (assay dependent)
3. Immunofluorescence staining: 1/100 dilution
4. Immunohistochemistry (assay dependent)
5. ELISA (assay dependent)

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS with 50 % Glycerol

Agent conservateur: Azide free

Stock: -20 °C

Détails sur VRK1

Antigène: VRK1 (Vaccinia Related Kinase 1 (VRK1))

Autre désignation: VRK1 (VRK1 Produits)

Synonymes: anticorps vrk1, anticorps MGC64390, anticorps MGC75762, anticorps VRK1, anticorps PCH1, anticorps PCH1A, anticorps 51PK, anticorps wu:fe16f06, anticorps zgc:56266, anticorps vaccinia related kinase 1 L homeolog, anticorps vaccinia related kinase 1, anticorps Serine/threonine-protein kinase VRK1, anticorps vrk1.L, anticorps vrk1, anticorps VRK1, anticorps vrk-1, anticorps Vrk1

Sujet: Function, The VRK1 gene encodes serine/threonine kinase VRK1 (Vaccinia-Related Kinase 1, 396 aa, 45.5 kDa) which is involved in Golgi disassembly during the cell cycle following phosphorylation by PLK3 during mitosis, and required to induce Golgi fragmentation. It acts by mediating phosphorylation of a downstream target protein 'Thr-18' of p53/TP53 and may thereby prevent the interaction between p53/TP53 and MDM2. It also phosphorylates casein and histone H3. Phosphorylation of the BANF1 gene product disrupts its ability to bind DNA, reduces its binding to LEM domain-containing proteins and causes its relocalization from the nucleus to the cytoplasm. Involvement in disease Defects in VRK1 are the cause of pontocerebellar hypoplasia type 1A (PCH1A), also called pontocerebellar hypoplasia with infantile spinal muscular atrophy or pontocerebellar hypoplasia with anterior horn cell disease. PCH1A is characterized by an abnormally small cerebellum and brainstem, central and peripheral motor dysfunction from birth, gliosis and anterior horn cell degeneration resembling infantile spinal muscular atrophy

ID gène: 7443

UniProt: Q99986